⌘K

Login Start Free

Home/Filings/4/A/0000899243-19-021423

4/A//SEC Filing

Royston Aaron 4/A

Accession 0000899243-19-021423

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 9:24 PM ET

Size

10.6 KB

Accession

0000899243-19-021423

Insider Transaction Report

Form 4/AAmended

Period: 2019-06-25

Menlo Therapeutics Inc.MNLO

Director

Transactions

Award
Stock Option
2019-06-25+22,500→ 22,500 total
Exercise: $6.02Exp: 2029-06-25→ Common Stock (22,500 underlying)

Footnotes (1)

[F1]The shares subject to the option will fully vest on the one year anniversary of the transaction date.

Documents

2 files

Issuer

Menlo Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1

filerCIK 0001727703

Filing Metadata

Form type: 4/A
Filed: Aug 7, 8:00 PM ET
Accepted: Aug 8, 9:24 PM ET
Size: 10.6 KB

View on SEC.gov